(Q46215271)

20 December 2017

title

Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib (English)

1 reference

20 December 2017

4

Caroline Robert

0 references

Patrick Bruneval

7

object named as

Patrick Bruneval

1 reference

20 December 2017

5

Jean-Michel Goujon

1 reference

20 December 2017

author name string

Guillaume Bollée

1

1 reference

20 December 2017

Natacha Patey

2

1 reference

20 December 2017

Géraldine Cazajous

3

1 reference

20 December 2017

Caroline Robert

4

1 reference

20 December 2017

Fadi Fakhouri

6

1 reference

20 December 2017

Laure-Hélène Noël

8

1 reference

20 December 2017

Bertrand Knebelmann

9

1 reference

20 December 2017

language of work or name

English

0 references

publication date

2 December 2008

1 reference

20 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

20 December 2017

volume

24

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

682-685

1 reference

20 December 2017

Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN657

VEGF inhibition and renal thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN657

Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN657

A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN657

Chronic thrombotic microangiopathy associated with antineoplastic therapy with minimal hematologic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN657

Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN657

The role of vascular endothelial growth factor (VEGF) in renal pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN657

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN657

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN657

21 January 2018

Identifiers

DOI

10.1093/NDT/GFN657

1 reference

20 December 2017

PubMed ID

19054798

1 reference

20 December 2017